Join to view full profile
3181 SW Sam Jackson Park RdPortland, OR 97239
Phone+1 503-494-7760
Fax+1 503-346-1501
Dr. Garzotto is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 1995 - 1999
University of FloridaResidency, Urology, 1992 - 1995- University of FloridaResidency, Surgery, 1990 - 1992
Louisiana State University School of Medicine in New OrleansClass of 1990
Certifications & Licensure
OR State Medical License 2000 - 2027
NY State Medical License 1995 - 2000
FL State Medical License 1992 - 1998
LA State Medical License 1990 - 1990
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
- S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
- Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer Start of enrollment: 2006 Apr 21
Publications & Presentations
PubMed
- Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled...Theodore L DeWeese, Andrea Manzanera, John Sylvester, Thomas Wheeler, Thomas Schroeder
The Lancet. Oncology. 2026-06-01 - Trans-cytolemmal water exchange in prostate manifest via DCE-MRI.Xin Li, Ryan P Kopp, William D Rooney, Charles S Springer Jr, Fergus V Coakley
Magma. 2026-04-15 - 1 citationsBody mass index and benign prostatic hyperplasia correlate with urinary microbiome diversity and lower urinary tract symptoms in men.Kate R Bowie, Mark Garzotto, Eric Orwoll, Lisa Karstens
Communications Medicine. 2025-05-07
Press Mentions
Polygenic Risk Score May Be Useful in Prostate Cancer Active SurveillanceJanuary 2nd, 2025- Exercise During Prostate Cancer Active Surveillance May Improve CV Risk FactorsAugust 9th, 2024
- Extended LND During Radical Cystectomy Offers No Overall Survival EdgeApril 7th, 2023
Grant Support
- P-2: The Effect Of RAD On Androgen Receptor Expression And Activity In ProstateNational Cancer Institute2010–2011
- The Effect Of Radiation On Androgen Receptor Expression And Activity In ProstateNational Cancer Institute2007–2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
